Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Bronchial Leiomyoma Companies

ID: MRFR/Pharma/3418-HCR
90 Pages
Vikita Thakur
Last Updated: February 16, 2025
Bronchial leiomyomas are rare tumors that arise from smooth muscle cells in the bronchi of the lungs. While information specific to companies exclusively focused on bronchial leiomyomas may be limited due to the rarity of the condition, medical institutions, oncology-focused companies, and research organizations may be involved in the diagnosis and treatment of such tumors.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Bronchial Leiomyoma Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)4.88%
2024 Market Size$ 90 Million
2025 Market Size$ 94.39 Million
2035 Market Size$ 152.01 Million

Key Players

Medtronic
Boston Scientific
Johnson & Johnson
Stryker
Smith & Nephew
B. Braun Melsungen AG
Opportunities
  • Enhanced Focus on Patient-Centric Care
  • Increasing Incidence of Bronchial Leiomyoma
  • Technological Advancements in Diagnostic Tools

Top Industry Leaders in the Bronchial Leiomyoma Market

Bronchial leiomyomas Market
ย 

Latestย Bronchial Leiomyomaย Companiesย Updates:

Cook Medical Received FDA approval for its PASSCO catheter, a specialized balloon dilatation device used for airway stenting, which could potentially be applied to manage symptoms caused by bronchial leiomyomas.

Siemens Healthineers Introduced the SOMATOM Force multi-detector CT scanner with AI-powered image reconstruction, potentially improving lung disease diagnosis, including bronchial leiomyomas.

Medtronic Continues to develop its portfolio of minimally invasive surgical instruments and energy devices, which could be relevant for future bronchial leiomyoma treatment options.

List ofย Bronchial Leiomyomaย Key companies in the market:

  • ย Hoffmann-La Roche Ltd (Europe)
  • AstraZeneca (Europe)
  • Eli Lilly and Company. (U.S.)
  • Sanofi (Europe)
  • Pfizer Inc. (U.S.)
  • GlaxoSmithKline Plc. (U.S.)
  • ArQule. (U.S.)
  • Boehringer Ingelheim GmbH (Europe)ย